These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 33062025)
1. Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Zhou M; Ye C; Liang Q; Pei Q; Xu F; Wen H Evid Based Complement Alternat Med; 2020; 2020():8391854. PubMed ID: 33062025 [TBL] [Abstract][Full Text] [Related]
2. Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Ou C; Yang YJ; Peng QH Evid Based Complement Alternat Med; 2019; 2019():6020846. PubMed ID: 31061670 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of traditional Chinese medicine injections for treating idiopathic pulmonary fibrosis: A systematic review and network meta-analysis. Huang SY; Cui HS; Lyu MS; Huang GR; Hou D; Yu MX PLoS One; 2022; 17(7):e0272047. PubMed ID: 35881610 [TBL] [Abstract][Full Text] [Related]
4. Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials. Guo J; Li B; Wu W; Wang Z; Wang F; Guo T Evid Based Complement Alternat Med; 2019; 2019():5170638. PubMed ID: 31312224 [TBL] [Abstract][Full Text] [Related]
5. [Meta-analysis of Yiqi Huoxue method in treating idiopathic membranous nephropathy]. Zheng QY; Sun LY; Jin HN; Zhou Q; Zhang W; Wang YH Zhongguo Zhong Yao Za Zhi; 2017 Sep; 42(18):3613-3622. PubMed ID: 29218950 [TBL] [Abstract][Full Text] [Related]
6. A Meta-Analysis of Randomized Controlled Trials of Yiqi Yangyin Huoxue Method in Treating Diabetic Nephropathy. Ou JY; Huang D; Wu YS; Xu L; He F; Wang HL; Shi LQ; Wan Q; He LQ; Dong Gao J Evid Based Complement Alternat Med; 2016; 2016():3257603. PubMed ID: 27313643 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of Yiqi Huoxue Yangxin decoction combined with western medicine in patients with chronic coronary heart disease: A protocol for systematic review and meta-analysis. Xie B; Wu B; Zhao M; Liu Y; Xu G; Li Q Medicine (Baltimore); 2022 Dec; 101(51):e32283. PubMed ID: 36595820 [TBL] [Abstract][Full Text] [Related]
8. [Network Meta-analysis of Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris]. Ji ZC; Hu HY; Yang FW; Zhang LS; Jin XY; Wang HC; Pang WT; Li N; Wang KY; Zhang JH Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1927-1937. PubMed ID: 31342723 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs. Yin B; Bi YM; Sun L; Huang JZ; Zhao J; Yao J; Li AX; Wang XZ; Fan GJ Front Public Health; 2021; 9():622707. PubMed ID: 34307269 [No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis. Ji K; Ma J; Wang L; Li N; Dong S; Shi L Evid Based Complement Alternat Med; 2020; 2020():1752387. PubMed ID: 32104189 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of YiQi HuoXue BuShen decoction combined with Western medicine on hypertensive nephropathy: a meta-analysis. Liu M; Wang H; Lv P Am J Transl Res; 2023; 15(6):3815-3824. PubMed ID: 37434822 [TBL] [Abstract][Full Text] [Related]
12. [Systematic review on Bushen Huoxue ricipe in treating patients suffering from diminished ovarian reserve]. Zhang HX; Ma K; Tong YJ Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(23):4464-4473. PubMed ID: 29376239 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis. Wu Q; Zhou Y; Feng FC; Zhou XM Chin J Integr Med; 2019 Oct; 25(10):778-784. PubMed ID: 29335860 [TBL] [Abstract][Full Text] [Related]
14. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention]. Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis: A systematic review and network meta-analysis. Pang Q; Li G; Cao F; Liu H; Wei W; Jiao Y PLoS One; 2022; 17(3):e0265006. PubMed ID: 35245333 [TBL] [Abstract][Full Text] [Related]
16. [Systematic review and Meta-analysis on efficacy and safety of Buzhong Yiqi Decoction for stable chronic obstructive pulmonary disease]. Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5344-5355. PubMed ID: 33350193 [TBL] [Abstract][Full Text] [Related]
17. Oral Chinese Herbal Medicine for Heart Failure with Preserved Ejection Fraction: A Meta-Analysis. Mei J; Xu H; Xu FQ; Ju JQ Chin J Integr Med; 2019 Oct; 25(10):770-777. PubMed ID: 31127505 [TBL] [Abstract][Full Text] [Related]
18. Effect of Yiqi Yangyin prescription in treatment of dilated cardiomyopathy: a Meta-analysis of randomized controlled trials. Zhou C; Li Q; Lu S; Zhang Z J Tradit Chin Med; 2017 Aug; 37(4):421-430. PubMed ID: 32188199 [TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Feng F; Zhang J; Wang Z; Wu Q; Zhou X Exp Ther Med; 2019 Jul; 18(1):802-816. PubMed ID: 31258714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]